Tokyo, Japan

Kimi Honma



Average Co-Inventor Count = 3.3

ph-index = 1

Forward Citations = 3(Granted Patents)


Location History:

  • Tokyo, JP (2011 - 2012)
  • Tokyo-to, JP (2014)

Company Filing History:


Years Active: 2011-2014

Loading Chart...
Loading Chart...
3 patents (USPTO):Explore Patents

Title: Kimi Honma: Innovator in Nucleic Acid Transfer and Cancer Treatment

Introduction

Kimi Honma is a notable inventor based in Tokyo, Japan. He has made significant contributions to the fields of nucleic acid transfer and cancer treatment. With a total of 3 patents, his work has the potential to impact medical science profoundly.

Latest Patents

Honma's latest patents include a method of promoting nucleic acid transfer. This invention provides a means for efficiently transferring a desired nucleic acid into a cell using a complex that comprises collagen or a collagen derivative. Another significant patent is a method of treating cancer with an RPN2 gene expression inhibitor. This invention utilizes an RPN2 gene expression inhibitor as a cancer cell growth inhibitor, which can be combined with a drug that shows anti-cancer action and administered with atelocollagen.

Career Highlights

Throughout his career, Kimi Honma has worked with reputable companies such as Koken Company, Limited and Dainippon Sumitomo Pharma Co., Ltd. His experience in these organizations has contributed to his expertise in the field of biotechnology and pharmaceuticals.

Collaborations

Honma has collaborated with notable colleagues, including Takahiro Ochiya and Kikuya Kato. Their joint efforts have likely enhanced the development and application of his innovative ideas.

Conclusion

Kimi Honma's contributions to nucleic acid transfer and cancer treatment exemplify the impact of innovation in medical science. His patents reflect a commitment to advancing healthcare solutions.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…